Blue Arbor Technologies
Blue Arbor Technologies is a Michigan-based medical device company developing the RESTORE Neuromuscular Interface System, an implanted electrode platform that connects advanced prosthetics to the peripheral nerves and muscles of upper-limb amputees for intuitive, multi-degree-of-freedom control.
- Company typePrivate
- Founded-
- HeadquartersAnn Arbor, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Blue Arbor Technologies firmographics
Firmographics- Name
- Blue Arbor Technologies
- Legal name
- Blue Arbor Technologies, Inc.
- Website
- https://bluearbortech.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Blue Arbor Technologies is a Michigan-based medical device company developing the RESTORE Neuromuscular Interface System, an implanted electrode platform that connects advanced prosthetics to the peripheral nerves and muscles of upper-limb amputees for intuitive, multi-degree-of-freedom control.
- Ownership category
- akta.pro rank
Blue Arbor Technologies industry classification
Industry- Product category
- Implantable Neuroprosthetic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
- akta.pro secondary industries
- Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems) (HLAHAEAH), Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets) (HLAHAMAD), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)
Keywords
Where Blue Arbor Technologies is headquartered
LocationHeadquarters
- HQ city
- Ann Arbor
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Blue Arbor Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Blue Arbor Technologies product offering
Product offeringCore offering
Blue Arbor Technologies develops the RESTORE™ Neuromuscular Interface System, an implantable medical device that establishes direct electrical connections to a patient's residual muscles and peripheral nerves to enable intuitive, multi-degree-of-freedom control of advanced prosthetic limbs for upper-limb amputees. The system uses implanted electrodes to capture stable neuromuscular signals that drive prosthetic movement, and has received FDA Breakthrough Device Designation.
Product overview
Blue Arbor Technologies offers a single unified medical device product: the RESTORE Neuromuscular Interface System. This system is designed to improve control and functionality of prosthetic limbs by directly linking with residual muscles and peripheral nerves. The technology achieved its first human implantation at the Medical University of Vienna in December 2025 and has received FDA Breakthrough Device Designation. Early feasibility trials demonstrated stable signal capture for more than five years.
Differentiator
Problem solved
Functional benefit
Brands
- RESTORE™ Neuromuscular Interface System: Neuromuscular interface technology that enables direct neural connections to peripheral nerves and muscles for intuitive, multi-degree-of-freedom prosthetic control.
Products and services
- RESTORE™ Neuromuscular Interface System
Quantifiable outcome
- Stable signal capture for more than five years demonstrated in early feasibility trials
- +1 more outcomes
Companies that use Blue Arbor Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
Blue Arbor Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Blue Arbor Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medical University of ViennacoreClinical trial partner where the first human implantation of the RESTORE system was successfully completed in December 2025. The university serves as a key research and clinical validation site for the neuromuscular interface technology.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Blue Arbor Technologies competitors and assessment
Company assessmentDirect peers
- Infinite Biomedical Technologies: Developer of myoelectric pattern-recognition controllers and sensors for upper-limb prosthetics. Comparable as a peer providing advanced control electronics for the same amputee population that Blue Arbor's RESTORE interface targets.
- PSYONIC: Developer of the Ability Hand, an advanced bionic upper-limb prosthesis with multi-DOF control. Comparable as a next-generation upper-limb prosthetic device targeting similar intuitive-control use cases.
- Coapt: Developer of pattern-recognition myoelectric control systems for prosthetic limbs. Closely comparable because it sells advanced prosthetic-control technology targeting the same upper-limb amputee population, but uses non-invasive surface electrodes rather than implanted ones.
- Atom Limbs: Developer of advanced multi-articulating prosthetic arms with sophisticated control schemes. Comparable as a next-generation upper-limb prosthetic platform competing for the same intuitive-control value proposition.
- Mobius Bionics (LUKE Arm): Commercializes the LUKE advanced prosthetic arm, a multi-DOF upper-limb prosthetic for amputees. Directly comparable end-product competitor to what Blue Arbor's RESTORE system is designed to control.
Broad incumbents
- Ottobock: Global market leader in prosthetics and exoskeletons and Blue Arbor's lead Series A investor and board seat holder. Directly comparable as a prosthetic-systems incumbent with overlapping patient populations in upper-limb amputation, though it sells complete prosthetic devices rather than an implanted interface.
Emerging players
- Synchron: Developer of an implanted brain-computer interface for motor control. Comparable as a peer in the implanted-neural-interface category competing for similar clinical and investor mindshare, though it targets cortical rather than peripheral nerve interfaces.
- BrainCo: Developer of brain-machine interface technology including prosthetic-limb control applications. Comparable as a peer working at the intersection of neural interfaces and prosthetic limb control.
- Paradromics: Implantable high-data-rate neural interface company. Comparable as another well-funded implanted-neural-interface peer working on restoring motor function through direct neural signal acquisition.
- Blackrock Neurotech: Implantable neural-interface company with long-duration human implants in motor cortex. Comparable as a fellow implantable neurotechnology player working on signal acquisition from the nervous system, though focused upstream of peripheral nerve/muscle interfaces.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Blue Arbor Technologies social profiles
Digital presenceBlue Arbor Technologies compliance and trust
Trust signalCompliance1 record
Blue Arbor Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Blue Arbor Technologies leadership team
Management profileNumber of profiles
Profiles3 records
Blue Arbor Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Blue Arbor Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Blue Arbor Technologies
What does Blue Arbor Technologies do?
Blue Arbor Technologies develops the RESTORE™ Neuromuscular Interface System, an implantable medical device that establishes direct electrical connections to a patient's residual muscles and peripheral nerves to enable intuitive, multi-degree-of-freedom control of advanced prosthetic limbs for upper-limb amputees. The system uses implanted electrodes to capture stable neuromuscular signals that drive prosthetic movement, and has received FDA Breakthrough Device Designation.
Is Blue Arbor Technologies a public or private company?
Blue Arbor Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Blue Arbor Technologies founded?
Blue Arbor Technologies was founded in -1. It employs 1 to 10 people.
Where is Blue Arbor Technologies based?
Blue Arbor Technologies is headquartered in Ann Arbor, United States, in the North America region.
Who are Blue Arbor Technologies's main competitors?
Direct peers on record are Infinite Biomedical Technologies, PSYONIC, Coapt, Atom Limbs and Mobius Bionics (LUKE Arm). Ottobock is listed as a broad incumbent. Emerging players are Synchron, BrainCo, Paradromics and Blackrock Neurotech.
Does Blue Arbor Technologies have an API?
No public API is recorded for Blue Arbor Technologies.
What industry is Blue Arbor Technologies in?
Blue Arbor Technologies's product category is Implantable Neuroprosthetic Medical Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS), with a secondary code of HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems). Its NAICS code is 334510 and its SIC code is 3845.